Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/1996
12/04/1996EP0745600A1 Benzimidazole derivatives, their preparation and their therapeutic use
12/04/1996EP0745584A1 Arylalkyl(thio) carboxamides compounds with affinity for melatonine receptors, processes for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745583A1 Alkoxy aryl compounds with affinity to the melatonine receptors, process for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
12/04/1996EP0745092A1 Peptide inhibitors of urokinase receptor activity
12/04/1996EP0744956A1 Peptides and methods against diabetes
12/04/1996EP0744955A1 Cyclic heptapeptide anti-inflammatory agent
12/04/1996EP0440738B1 Treatment of hypertension
12/04/1996CN1137274A 6-oxo-nucleosides useful as immunosuppressants
12/04/1996CN1137268A Amidino derivatives useful as nitric oxide synthase inhibitors
12/04/1996CN1137035A Basic group substituted benzoyl guanidine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same
12/04/1996CN1136960A Polyamines and polypeptides useful as antagonisis of excitatory amino acid neurotransmitiers and/or as blockers of calcium channels
12/04/1996CN1136954A Method for producing Chinese patent medicine for curing diabetes and its pill
12/04/1996CN1136953A Medicine for treating diabetes
12/04/1996CN1136920A Use of benzopyran derivatives for production of pharmaceutical compositions
12/03/1996US5580953 Useful in therapy of type 2 diabetes mellitus, impaired glucose tolerance, obesity and insulin resistance
12/03/1996US5580884 Antimicrobial agents
12/03/1996US5580881 1,2,3,5,6,7,8,8a-Octahydro-5,5,8a-trimethyl-(8aβ)-6-isoquinolineamine derivatives, preparation method therefor and therapeutical use thereof
12/03/1996US5580723 Comparing the activities of a segment-substituted polypeptide and the parent polypeptide; borrowing receptor binding properties from functionally divergent hormones
11/1996
11/28/1996WO1996037517A1 Rhesus ob protein and dna
11/28/1996WO1996037514A1 Chimeric fatty body-pro-grf analogs with increased biological potency
11/28/1996WO1996037500A1 Novel quinoxaline dione derivatives, their production and their use in medicaments
11/28/1996WO1996037223A1 Muscle trophic factor
11/28/1996WO1996037216A1 Method of administration of igf-i
11/28/1996WO1996037201A2 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY
11/28/1996WO1996037196A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996DE19519979A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments
11/28/1996CA2222018A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996CA2221824A1 Rhesus ob protein and dna
11/28/1996CA2221695A1 New quinoxalinedione derivatives, their production and use in pharmaceutical agents
11/28/1996CA2221236A1 Methods and compositions for inhibiting 5.alpha.-reductase activity
11/28/1996CA2218018A1 Method of administration of igf-i
11/27/1996EP0744408A2 Rhesus ob protein and DNA
11/27/1996EP0744397A2 Fluorophenyl substituted alkenyl carboxylic acid guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agent as well as a medicament containing them
11/27/1996EP0744176A2 Methods for inhibiting bone loss
11/27/1996EP0743945A1 Heterocyclic compounds and their preparation and use
11/27/1996EP0743944A1 Azacyclic derivatives
11/27/1996CN1136808A Pseudodipeptide product having imidazole grouping and applications
11/27/1996CN1136566A Indole derivatives
11/27/1996CN1136565A Indole derivatives
11/27/1996CN1136562A Estrogen excitant/antagonist
11/27/1996CN1136557A Para retinoic acid
11/27/1996CN1136435A Application of pyromeconic acid and heteroside (erigeron glucoside) in pharmacy
11/27/1996CN1136432A Indole derivatives
11/26/1996US5578708 Derived from bones of mammals including mice and humans; diagnosis and therapy for bone metabolic diseases
11/26/1996US5578639 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
11/26/1996US5578634 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors
11/26/1996US5578617 Method and compositions for treating age related disorders
11/26/1996US5578614 Methods for inhibiting weight gain or inducing weight loss
11/26/1996US5578613 Methods for inhibiting weight gain or inducing weight loss
11/26/1996US5578612 Indole derivatives
11/26/1996US5578572 Anti-gram-positive bacterial methods and materials
11/26/1996US5578569 Method of increasing bone growth
11/26/1996US5578469 Process for preparing neotrehalose, and its uses
11/26/1996CA2078287C Nitroxides as protectors against oxidative stress
11/24/1996CA2177115A1 Methods for inhibiting bone loss
11/21/1996WO1996036644A1 Obesity gene product
11/21/1996WO1996036638A1 Xanthines and their therapeutic use
11/21/1996WO1996036609A1 Quinolyl-ethynyl derivatives having retinoid-like activity
11/21/1996WO1996036348A1 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
11/21/1996WO1996036334A1 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors
11/21/1996WO1996036327A1 Method of modulating microcirculation
11/21/1996WO1996036325A1 Agents for reducing weight
11/21/1996WO1996036244A1 Application of phospholipases in animal feed
11/21/1996WO1996030042A3 Methods of treating inflammation and compositions therefor
11/21/1996CA2221303A1 Obesity gene product
11/21/1996CA2221131A1 Quinolyl-ethynyl derivatives having retinoid-like activity
11/21/1996CA2218548A1 Xanthines and their therapeutic use
11/20/1996EP0743321A2 Obesity gene product
11/20/1996EP0743301A2 Benzoylguanidines containing fluorine
11/20/1996EP0742818A1 Macroencapsulated secretory cells
11/20/1996EP0742715A1 Oral liquid compositions containing paroxetine resinate
11/20/1996EP0648108B1 Prophylactic and therapeutical preparation against caries
11/20/1996CN1136316A Biologically active silicon compounds and their therapeutic and cosmetic applications
11/20/1996CN1136315A Method for preparing concentrated biologically active silicon compounds
11/20/1996CN1136312A Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1136311A Novel benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1136278A Combination of bisphosphonates and growth hormone secretagogues
11/20/1996CN1136266A 新的饮料 New beverage
11/19/1996US5576442 Reduction of ketone with borane in the presence of oxazaborolidine catalyst in cyclic ether solvent
11/19/1996US5576340 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses
11/19/1996US5576337 Method of treating anxiety by inhibiting physiological conditions associated with an excess of neuropeptide Y
11/19/1996US5576321 Compounds having effects on serotonin-related systems
11/19/1996US5576287 Method for treating acute renal disease and failure
11/19/1996CA2106200C Stereoselective preparation of substituted piperidines
11/17/1996CA2176553A1 Fluorine-containing benzoylguanidines
11/16/1996CA2176634A1 Application of phospholipases in animal feed
11/14/1996WO1996035805A2 Tripeptidylpeptidase inhibitors
11/14/1996WO1996035787A1 Nucleic acids for treating obesity
11/14/1996WO1996035774A2 Angiostatin fragments and aggregate angiostatin and methods of use
11/14/1996WO1996035711A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996WO1996035681A1 Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them
11/14/1996WO1996035671A1 β-ADRENERGIC AGONISTS
11/14/1996WO1996035670A1 β-ADRENERGIC AGONISTS
11/14/1996WO1996035447A1 Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours
11/14/1996WO1996035445A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent
11/14/1996WO1996035443A1 Treatment for inhibiting the progression of autoimmune disease
11/14/1996WO1996035439A1 Low molecular yeast active substance extract and process for preparing the same
11/14/1996WO1996035421A1 High-dose chromic tripicolinate for the treatment of type ii diabetes
11/14/1996WO1996032087A3 Transgenic fish in the treatment of diabetes
1 ... 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 ... 1298